Pharma Mar SA is a pharmaceutical company based in Spain that focuses on researching, developing, and producing bio-active marine ingredients for oncology treatments. They also manufacture products for household use, such as insecticides and air fresheners. Pharma Mar SA operates in four segments including Oncology, Diagnostics, Consumer chemicals, and RNAi. With a medium risk ESG score of 25.2, Pharma Mar SA generates revenue primarily from biopharmaceuticals.